中國網浪潮新聞 北京時間6月19日晚間，浙江台州的一家藥企發佈公開稱，該藥企擬出資11,000萬歐元（約合人民幣83,733萬元）收購義大利　Newchem　S.P.A.和Effechem　S.r.l.100%的股權。

CNCAO NEWS At the night of June 19th , Beijing time, a pharmaceutical company of Taizhou, Zhejiang released publicly that they intended to invest 110 million Euros (about 837.330 million yuan)to acquired 100% shares of Italy Newchem S.P.A. and Effechem S.r.l.

　　據了解，該藥企為浙江仙琚制藥股份有限公司，創建於1972年，目前是中國甾體激素類藥物的龍頭企業。2010年1月成為台州仙居縣第一家上市公司。

It is understood that Zhejiang Xianju Pharmaceutical Co., Ltd. which was founded in 1972, is currently the China leading enterprises producing steroid hormone. It became the first listed company in Xianju County, Taizhou in January 2010.

　　其收購的兩家義大利藥企均為仙琚制藥公司多年的合作夥伴，也是其拿下的第一個全資項目。

These two Italy pharmaceutical companies merged by it are its partners for many years and are also the first wholly-owned projects of Xianju Pharmaceutical Co., Ltd.

　　據台州市經信委稱，台州作為浙江對外開放前沿，當地政府積極推動當地企業參與海外並購重組，成為台州融入“一帶一路”新格局的重要舉措。

According to the Taizhou Province Economic and Information Commission, as the forefront of Zhejiang’s opening up, the government of Taizhou actively promotes local enterprises to participate in overseas mergers and acquisitions, which has become an important measure of Taizhou integrating into the new pattern of "The Belt and Road".

　　2009年至今，該市18家企業開展海外並購重組19筆，並購金額達24，281萬美元，涉及13個國家和地區。其中歐洲7筆，佔比36.84%。

Since 2009, 18 enterprises of the city have 19 overseas mergers and acquisitions, and the amount of which reached to $242.810 million, involving 13 countries and regions. And 7 of 19 are in Europe, accounting for 36.84%.

來源： 中國網    | 作者：見習邱玉潔 實習生陳丹娜 杜依依譯    | 責編：楊雲寒    審核：張淵

新聞投稿：184042016@qq.com    新聞熱線：13157110107